title: Vigabatrin aggravates absences and absence status.
authors.affiliation: Department of Clinical Neurophysiology and Epilepsies, St. Thomas' Hospital, London, UK.
authors.forename: C P
authors.initials: CP
authors.lastname: Panayiotopoulos
authors.forename: A
authors.initials: A
authors.lastname: Agathonikou
authors.forename: I A
authors.initials: IA
authors.lastname: Sharoqi
authors.forename: A P
authors.initials: AP
authors.lastname: Parker
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects*; D004569:Electroencephalography; D004832:Epilepsy, Absence / Q000139:chemically induced* / Q000503:physiopathology; D004829:Epilepsy, Generalized / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D020888:Vigabatrin; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000927:Anticonvulsants; D005680:gamma-Aminobutyric Acid; D020888:Vigabatrin